SLGN:NYSESilgan Holdings Inc. Analysis
Data as of 2026-05-01 - not real-time
$40.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Silgan Holdings (SLGN) is trading at $40.55, below its 20‑day ($40.41) and 50‑day ($42.04) moving averages, indicating a short‑term bearish bias, yet the MACD histogram has turned positive and volume is rising, hinting at a possible near‑term bounce toward the $42.36 resistance.
Fundamentally, the stock appears undervalued with a forward P/E of 9.94, price‑to‑sales of 0.65 and a dividend yield of 2.07% supported by a modest 30% payout ratio. Analysts are overwhelmingly positive – a “strong_buy” consensus, a mean target of $53.92 (≈32% upside) and Deutsche Bank has just initiated coverage with a Buy rating. The company faces high leverage (debt‑to‑equity >200%) and elevated 30‑day volatility (~31%), but its low beta (0.67) and solid cash flow generation mitigate some risk. Upcoming Q1 earnings on April 29 will be a key catalyst to confirm momentum.
Fundamentally, the stock appears undervalued with a forward P/E of 9.94, price‑to‑sales of 0.65 and a dividend yield of 2.07% supported by a modest 30% payout ratio. Analysts are overwhelmingly positive – a “strong_buy” consensus, a mean target of $53.92 (≈32% upside) and Deutsche Bank has just initiated coverage with a Buy rating. The company faces high leverage (debt‑to‑equity >200%) and elevated 30‑day volatility (~31%), but its low beta (0.67) and solid cash flow generation mitigate some risk. Upcoming Q1 earnings on April 29 will be a key catalyst to confirm momentum.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support at $38.5
- Bullish MACD histogram and rising volume
- High short‑term volatility limiting upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst consensus strong‑buy with mean target $53.9
- Undervalued valuation multiples (forward P/E ~10)
- Upcoming earnings release could confirm upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable dividend yield and sustainable payout
- Long‑term cash flow generation despite high leverage
- Industry position in essential consumer packaging
Key Metrics & Analysis
Financial Health
Revenue Growth6.50%
Profit Margin4.31%
P/E Ratio15.2
ROE12.87%
ROA4.52%
Debt/Equity200.83
P/B Ratio1.9
Op. Cash Flow$613.6M
Free Cash Flow$275.3M
Technical Analysis
TrendBearish
RSI50.2
Support$38.50
Resistance$42.36
MA 20$40.41
MA 50$42.04
MA 200$43.30
MACDBullish
VolumeIncreasing
Fear & Greed Index90.98
Valuation
Fair Value$5.75
Target Price$53.92
Upside/Downside32.96%
GradeUndervalued
TypeBlend
Dividend Yield2.07%
Risk Assessment
Beta0.67
Volatility30.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.